Theriva Biologics, Inc (TOVX) insider trading
Every open-market stock purchase and sale by Theriva Biologics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Steven A Shallcross (CEO), $9.7K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent TOVX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jan 5, 2026 | Jeffrey J Kraws (Director) | Bought (not open market) | — |
| Jan 5, 2026 | Steven A Shallcross (CEO) | Bought (not open market) | — |
| Jan 5, 2026 | Jeffrey Alan Wolf (Director) | Bought (not open market) | — |
| Jan 5, 2026 | John J Monahan (Director) | Bought (not open market) | — |
Who's trading TOVX
- Jeffrey J Kraws, Director: other filings, last Jan 5, 2026
- John J Monahan, Director: other filings, last Jan 5, 2026
- Steven A Shallcross, CEO: other filings, last Jan 5, 2026
- Jeffrey Alan Wolf, Director: other filings, last Jan 5, 2026
Get free alerts when an insider at Theriva Biologics, Inc files a new trade →